Mydekla 60mg tablets
Mydekla tablet is a drug containing the active component of Daclatasvir and is used to treat hepatitis C. This article contains information on instructions for using this drug, indications, and contraindications to its use, describes possible side effects, reviews of doctors and patients about this drug, price, which you can buy the drug.
Mydekla (Daclatasvir 60mg) component of the drug
Daclatasvir blocks the multiplication of the HCV virus and its spread from infected liver cells through the body, preventing damage to healthy cells. This property allows the use of drugs with Daclatasvir for the treatment of hepatitis C. In addition to the original antiviral drugs, generics are also used, the cost of which is much lower.
Buy and Price Mydekla Daclatasvir 60mg Now!
The price at which you can buy Daclatasvir depends on the manufacturer of the drugs in which it is included. Optimum in price and quality are the Indian preparations of Daclatasvir.
You can buy this component as part of the preparation Mydekla, and separately. One package contains 28 tablets of 60 mg each. A minimum course of treatment requires 80 tablets. You can buy the medicine in the pharmacy or on the official website,
Often, Daclatasvir is administered jointly with Sofosbuvir. After registration of the application on the site, the manager is contacted by the buyer to specify the details of the shipment. Delivery is carried out in accordance with the standards of transportation: the drug is sealed in a thermo-packaging to preserve its properties. This is a 100% guarantee that the customer will receive a quality product.
How much does Daclatasvir
|Name of the drug||Price for 1 packing|
As can be seen from the table, the cost of Daclatasvir for 1 pack of 28 tablets varies depending on the manufacturer; the price of the original drug is higher than that of generics.
Instructions for Use of Daclatasvir
The instructions for the use of Daclatasvir detail the indications and contraindications for admission, the rules and duration of treatment, its composition is indicated.
In the package with the original Mydekla medicine, instructions in India should be followed. The rules of application are also set out on the official website. One of the most effective and common treatment regimens is the simultaneous reception of Daclatasvir and Sofosbuvir.
Following this instruction, the drug is taken per of – orally, without crushing, squeezed with a small amount of liquid. The daily dose is not divided; it is consumed immediately – at one time. It is necessary to take the medicine at the same time, during or after a meal.
The daily dose is 60 mg, its excess is not allowed. If the patient is not sure whether he drank the pills or not, it is better to skip the reception than to use a double amount of the drug. In some cases, dosage reduction is possible. Elderly age is not an indication for dose reduction. The duration of treatment for hepatitis is determined by the doctor, on average, it is 3-6 months.
During treatment, alcoholic beverages are unacceptable. For the period of therapy should refuse to accept enter sorbents, as they reduce the content of the drug in the blood.
Before the beginning of treatment of hepatitis, the patient should inform the doctor about the presence of contraindications.
Reception of Daclatasvir is contraindicated in the following cases:
- The age is younger than 18 years, as there have been no studies on the safety of this drug by patients in this group.
- Hypersensitivity to the components of the drug, including lactose.
- Breastfeeding and breastfeeding. It was found that the active substance of the drug is able to penetrate into breast milk.
For the period of treatment and for a month after its termination, spouses should be protected from conception in order to prevent possible negative effects of the drug on the fetus.
Cirrhosis of the liver is not a contraindication to the therapy with Daclatasvir. Substances that can reduce the effectiveness of Daclatasvir: Phenobarbital, St. John’s Wort, dexamethasone, rifabutin, carbamazepine, rifampicin.